Sirtris Pharmaceuticals, Inc. - Current report filing (8-K)
May 02 2008 - 11:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported):
May 1, 2008
SIRTRIS
PHARMACEUTICALS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-33465
|
|
20-1410189
|
(State or other
jurisdiction of
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
200
Technology Square, Cambridge, Massachusetts 02139
(Address
of Principal Executive Offices) (Zip
Code)
Registrants
telephone number, including area code:
(617) 252-6920
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 2.02 Results
of Operations and Financial Condition.
On May 1, 2008,
Sirtris Pharmaceuticals, Inc. issued a press release relating to its
results of operations and financial conditions for the fiscal year ended March 31,
2008. A copy of the press release is furnished as Exhibit 99.1 to this
form 8-K.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits
99.1
|
|
Press Release issued by
Sirtris Pharmaceuticals, Inc. on May 1, 2008.
|
2
Signature
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
SIRTRIS
PHARMACEUTICALS, INC.
|
|
|
Date: May 1, 2008
|
By:
|
/s/
CHRISTOPH WESTPHAL
|
|
|
Name:
|
Christoph Westphal
|
|
Title:
|
President and Chief
Executive Officer
|
3
Index
to Exhibits
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release issued by
Sirtris Pharmaceuticals, Inc. on May 1, 2008.
|
4
Sierra Natl BK Tehachapi Calif (MM) (NASDAQ:SIRT)
Historical Stock Chart
From Apr 2024 to May 2024
Sierra Natl BK Tehachapi Calif (MM) (NASDAQ:SIRT)
Historical Stock Chart
From May 2023 to May 2024